-
Re “Inhaled Corticosteroid Particle Size and Risk of Hospitalization Rue to Exacerbations and All-Cause Mortality in Patients With Chronic Obstructive Respiratory Disease. A Nationwide Cohort Study”. Heerfordt et al [Letter]
05 Feb 2025 15:46 GMT
… to the study titled “Inhaled Corticosteroid particle size and risk of … , Eklöf J, et al. Inhaled corticosteroids particle size and risk of … -acting β2-agonist plus inhaled corticosteroid fixed-dose combinations in COPD …
-
Atopic Dermatitis Treatments Before and After Initiation of Ruxolitinib Cream: 6-Month Follow-Up Analysis of a US Payer Claims Database
06 Feb 2025 08:13 GMT
… treated with biologics, systemic corticosteroids, systemic immunosuppressants, phototherapy, … use of biologics, systemic corticosteroids, systemic immunosuppressants, phototherapy, … topical/oral corticosteroids and biologics, potentially simplifying …
-
Clinical Burden and Healthcare Resource Use of Asthma in Children in the UK
06 Feb 2025 08:13 GMT
… prescription) of oral corticosteroids (OCS) or injectable corticosteroids according to the CPRD …
-
Alopecia Market to Grow to US$ 27.7 Billion by 2033 at a 10.5% CAGR
06 Feb 2025 09:38 GMT
… new medications, traditional treatments like corticosteroids and Minoxidil are still in … )], Oral [OTC, Prescription (Minoxidil, Finasteride, Corticosteroids, Others)], PRP}
• Devices (Laser Cap …
-
A Prospective, Crossover, Randomized, Double-Blind Clinical Study Comparing the Effectiveness and Ocular Comfort of 0.1% Hyaluronic Acid and 0.3% Hyaluronic Acid in Patients With Dry Eye Disease
06 Feb 2025 08:13 GMT
… cyclosporine A, or short-term corticosteroids may be prescribed. Recently, the …
-
Inhaled Triple Therapy Needs Better Integration into Asthma Care
06 Feb 2025 01:39 GMT
… least average doses of inhaled corticosteroids (ICS) combined with long-acting …
-
Computational Phenotyping of Obstructive Airway Diseases: A Systematic Review
06 Feb 2025 01:14 GMT
… higher doses of ICS, oral corticosteroids (OCS), additional controller, regular use …
-
FDA Grants ADI-001 Fast Track Designation as Treatment of Refractory Systemic Lupus Erythematosus
06 Feb 2025 01:04 GMT
… health care professionals might prescribe corticosteroids, such as prednisone, to reduce …
-
New England Journal of Medicine Publishes Results of Global, Multicenter eNRGy Study Evaluating Zenocutuzumab-zbco (BIZENGRI®) in NRG1+ cancer
05 Feb 2025 23:52 GMT
… ILD/pneumonitis and administer corticosteroids as clinically indicated.
Permanently discontinue …
-
Type II JAK Inhibitor AJ1-11095 Under Phase 1 Investigation in Myelofibrosis
05 Feb 2025 22:53 GMT
… -11095; ongoing use of systemic corticosteroids at a dose equivalent to …